Kathryn C. Zoon

Insider Reports History

Location
400 Professional Drive, Suite 400, Gaithersburg, MD
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathryn C. Zoon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 71.8K $637K $8.87 Aug 15, 2025 Direct
Emergent BioSolutions Inc. Director Stock Option (Right to Buy) 41.6K Apr 30, 2025 Direct

Insider Reports Filed by Kathryn C. Zoon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. Aug 15, 2025 1 -$62.9K 4 Aug 18, 2025 Director
EBS Emergent BioSolutions Inc. Apr 30, 2025 2 $0 4 May 2, 2025 Director
EBS Emergent BioSolutions Inc. Mar 12, 2025 1 -$57.3K 4 Mar 12, 2025 Director
EBS Emergent BioSolutions Inc. Jun 4, 2024 1 -$61.1K 4 Jun 6, 2024 Director
EBS Emergent BioSolutions Inc. May 29, 2024 1 -$8.44K 4 May 31, 2024 Director
EBS Emergent BioSolutions Inc. May 23, 2024 2 $0 4 May 28, 2024 Director
EBS Emergent BioSolutions Inc. May 21, 2024 1 -$6.29K 4 May 23, 2024 Director
EBS Emergent BioSolutions Inc. May 25, 2023 2 -$29.5K 4 Jul 24, 2023 Director
EBS Emergent BioSolutions Inc. May 25, 2023 1 $0 4 May 30, 2023 Director
EBS Emergent BioSolutions Inc. Jun 9, 2022 1 -$37K 4 Jun 13, 2022 Director
EBS Emergent BioSolutions Inc. May 26, 2022 1 $0 4 May 31, 2022 Director
EBS Emergent BioSolutions Inc. May 24, 2022 1 -$70.9K 4 May 25, 2022 Director
EBS Emergent BioSolutions Inc. May 25, 2021 1 -$177K 4 May 27, 2021 Director
EBS Emergent BioSolutions Inc. May 20, 2021 1 $0 4 May 24, 2021 Director